Update from the Medication Safety programme – 30 September 2014

30 Sep 2014 | Medication Safety

Medication safety national forum – launch of campaign

Due to a high level of interest, the venue for the Medication Safety Forum on 16 October 2014 has been moved to the Deloitte Gallery at the Westpac Stadium. The final programme and guidance on storyboard presentations, is available here. We look forward to seeing you there.

We will be videoing most of the day, especially the key note addresses and presentations, and will post these onto the website for those who are unable to attend.

Campaign focus – Reducing harm from high-risk medicines

From October 2014 to March 2015, the Open for better care campaign will focus on reducing harm from high-risk medicines. In October we will be exploring what the high-risk medicines issues are and why special attention is needed when they are prescribed, dispensed, supplied, stored and taken.

Tell us about the activities you and your organisation are planning to raise awareness of high-risk medicines. Email your stories to info@hqsc.govt.nz so that we can share them across the sector.

Safe use of opioids collaborative

The safe use of opioids collaborative starts in October 2014, and runs for 18 months. The Commission’s medication safety team is currently organising the first collaborative meetings (regional learning sessions – often referred to as learning session zero). These will take place in Palmerston North (October 21), Auckland (October 23) and Hamilton (October 29). The Northern region session will be run in partnership with First, Do No Harm. A date for the South Island session is yet to be confirmed – it is likely to be in early-mid November. Following these regional events a series of three national learning set will be planned.

The national expert faculty guiding the collaborative has been established. The group met on 26 September to discuss and identify possible interventions and measurement approaches that district health boards (DHBs) may choose to work on during the collaborative.

We encourage collaborative teams, and wider DHB representation, at the regional learning session zero’s, as this will be a time where the infrastructure to support collaborative teams will also be discussed.

Expert faculty members include:

  • Avril Lee, Clinical Lead, safe use of opioids collaborative, Waitemata DHB
  • Dr Carol McAllum, Palliative Medicine Specialist, Clinical Director Palliative Care, Hawke’s Bay DHB
  • Dr Michal Kluger, Anaesthesiologist and Pain Physician, Waitemata DHB
  • Dr Chris Cameron, General Physician & Clinical Pharmacologist, Capital & Coast DHB
  • Dr Wendy Pattemore, Palliative Care Specialist, Christchurch
  • Dr Murray Hunt, Medical Director of Waipuna Hospice, Tauranga
  • Professor Stephan A. Schug, Chair of Anaesthesiology, Pharmacology, Pharmacy and Anaesthesiology Unit, University of Western Australia, Director of Pain Medicine, Royal Perth Hospital
  • Caroline Tilah, Director (Operations), Quality Improvement and Patient Safety Directorate, Capital & Coast DHB
  • Dr Kieran Davis, Clinical Director, The Auckland Regional Pain Service
  • Sue King, Nurse Practitioner - Pain Management, Waikato DHB

 

Last updated 02/10/2014